Key Facts

Latest information about our company.


Global Business

Updated January 2017

Chief Executive Officer:
Headquarters:
New York City
Business:
Biopharmaceuticals
Web Address:
NYSE Listing:
BMY
Net Global Sales:
$19.4 billion in 2016
R&D Investment:
$4.94 billion which included the discovery and development of new medicines for patients
Principal Locations:

Local Business

Updated November 2017

General Manager:
Alan Reba
Local Headquarters:

Montreal, Canada

Address:
2344 Alfred-Nobel,
Suite 300
Saint-Laurent, QC
H4S 0A4
CANADA

Key Products:
ELIQUIS® (apixaban)
OPDIVO® (nivolumab)
ORENCIA® (abatacept)
SPRYCEL® (dasatinib)
YERVOY® (ipilimumab)